Clinical Trial Update: A Study to Evaluate the Effectiveness and Safety of Tapentadol(CG5503) in the Treatment of Acute Pain After Hip Replacement Surgery Compared With Oxycodone and Placebo Followed by a Voluntary Open-Label Extension For Safety [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating tapentadol CG5503 for acute postoperative pain after hip replacement, compared with oxycodone and placebo, was terminated, with resul…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoarthritis of the Hip
• Postoperative Pain

Drugs mentioned

• Oxycodone (oxycodone)
• Tapentadol CG5503 (tapentadol)

Snippet

Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Conditions: Arthroplasty | Phase 3 | Status: TERMINATED | Results posted: 2009-07-08